Thorgerdur Palsdottir

Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality

Lars Björnebo, Tobias Nordström, Andrea Discacciati et al. · JAMA Oncology · 2022 · 40 citations · Full text

Medicine, Pharmacology, Urology +17

Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50–69 years with PSA ≥3 ng/ml

Jan Chandra Engel, Thorgerdur Palsdottir, Markus Aly et al. · Scandinavian Journal of Urology · 2019 · 28 citations · Full text

Medicine, Oncology, Urology +17

Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators

Ashkan Mortezavi, Thorgerdur Palsdottir, Martin Eklund et al. · European Urology Focus · 2020 · 27 citations · Full text

Medicine, Oncology, Urology +17

The impact of different prostate-specific antigen (PSA) testing intervals on Gleason score at diagnosis and the risk of experiencing false-positive biopsy recommendations: a population-based cohort study

Thorgerdur Palsdottir, Tobias Nordström, Andreas Karlsson et al. · BMJ Open · 2019 · 22 citations · Full text

Medicine, Oncology, Urology +17

A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging

Thorgerdur Palsdottir, Tobias Nordström, Markus Aly et al. · European Urology Oncology · 2018 · 19 citations · Full text

Medicine, Oncology, Urology +14